These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24481117)

  • 1. Returning pleiotropic results from genetic testing to patients and research participants.
    Kocarnik JM; Fullerton SM
    JAMA; 2014 Feb; 311(8):795-6. PubMed ID: 24481117
    [No Abstract]   [Full Text] [Related]  

  • 2. To tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.
    Christenhusz GM; Devriendt K; Dierickx K
    Eur J Hum Genet; 2013 Mar; 21(3):248-55. PubMed ID: 22739341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic test validation for incidental findings.
    Park JY; Fortina P; Kricka LJ
    Clin Chem; 2014 Feb; 60(2):292-3. PubMed ID: 23818443
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidental variants are critical for genomics.
    Biesecker LG
    Am J Hum Genet; 2013 May; 92(5):648-51. PubMed ID: 23643378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental benefits.
    Nature; 2012 Mar; 483(7390):373. PubMed ID: 22437569
    [No Abstract]   [Full Text] [Related]  

  • 6. Reporting genomic sequencing results to ordering clinicians: incidental, but not exceptional.
    Green RC; Lupski JR; Biesecker LG
    JAMA; 2013 Jul; 310(4):365-6. PubMed ID: 23917280
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Information is information': a public perspective on incidental findings in clinical and research genome-based testing.
    Daack-Hirsch S; Driessnack M; Hanish A; Johnson VA; Shah LL; Simon CM; Williams JK
    Clin Genet; 2013 Jul; 84(1):11-8. PubMed ID: 23590238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biobanks: Validate gene findings before telling donors.
    Hansson MG
    Nature; 2012 Apr; 484(7395):455. PubMed ID: 22538599
    [No Abstract]   [Full Text] [Related]  

  • 9. Disclosure of Misattributed Paternity.
    Prero MY; Strenk M; Garrett J; Kessler A; Fanaroff JM; Lantos JD
    Pediatrics; 2019 Jun; 143(6):. PubMed ID: 31097466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA donor rights affirmed.
    Hayden EC
    Nature; 2012 Mar; 483(7390):387. PubMed ID: 22437587
    [No Abstract]   [Full Text] [Related]  

  • 11. Mandatory extended searches in all genome sequencing: "incidental findings," patient autonomy, and shared decision making.
    Ross LF; Rothstein MA; Clayton EW
    JAMA; 2013 Jul; 310(4):367-8. PubMed ID: 23917281
    [No Abstract]   [Full Text] [Related]  

  • 12. Beyond Recommendation: Requiring Returning Findings to Research Participants.
    Wurst T; Terry SF
    Genet Test Mol Biomarkers; 2018 Mar; 22(3):141-142. PubMed ID: 29565740
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical signposts for clinical geneticists in secondary variant and incidental finding disclosure discussions.
    Christenhusz GM; Devriendt K; Van Esch H; Dierickx K
    Med Health Care Philos; 2015 Aug; 18(3):361-70. PubMed ID: 25407129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To disclose, or not to disclose? Perspectives of clinical genomics professionals toward returning incidental findings from genomic research.
    AlFayyad I; Al-Tannir M; Abu-Shaheen A; AlGhamdi S
    BMC Med Ethics; 2021 Jul; 22(1):101. PubMed ID: 34315465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disclosure of sex when incidentally revealed as part of preimplantation genetic testing (PGT): an Ethics Committee opinion.
    ;
    Fertil Steril; 2018 Sep; 110(4):625-627. PubMed ID: 30196948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Conceptual Understanding of the "Actionability" of Incidental Findings and the Resultant Difference in Ethical Responsibility: An Empirical Study in Japan.
    Ibuki T; Yamamoto K; Matsui K
    AJOB Empir Bioeth; 2020; 11(3):187-194. PubMed ID: 32615058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revealing the incidentalome when targeting the tumor genome.
    Bombard Y; Robson M; Offit K
    JAMA; 2013 Aug; 310(8):795-6. PubMed ID: 23982363
    [No Abstract]   [Full Text] [Related]  

  • 18. The question not asked: the challenge of pleiotropic genetic tests.
    Wachbroit R
    Kennedy Inst Ethics J; 1998 Jun; 8(2):131-44. PubMed ID: 11657425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disclosing individual genetic research results to deceased participants' relatives by means of a qualified disclosure policy.
    Bredenoord AL; van Delden JJ
    Am J Bioeth; 2012; 12(10):10-2. PubMed ID: 22974019
    [No Abstract]   [Full Text] [Related]  

  • 20. Defining categories of actionability for secondary findings in next-generation sequencing.
    Moret C; Mauron A; Fokstuen S; Makrythanasis P; Hurst SA
    J Med Ethics; 2017 May; 43(5):346-349. PubMed ID: 28039284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.